Unknown NA INTERVENTIONAL 1-arm NCT05513469

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses (Radio-Marker)

Sponsor: Erasmus Medical Center

Interventions Lutathera

Updated 5 times since 2022 Last updated: Apr 6, 2023 Started: Jan 1, 2023 Primary completion: Oct 1, 2024 Completion: Oct 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Neuroendocrine Tumors and is currently ongoing. Erasmus Medical Center leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

May 2025 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — May 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
May 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2022 — May 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Erasmus Medical Center

Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rotterdam, Netherlands